• SENSEX 71,593.24
    -1,045.46 (--1.44%)
  • BANKNIFTY 54,515.05
    -540.50 (--0.98%)
  • ITC
    253.15 253.15(%)
  • Kanohar Elect.
    1,210.00 1,210.00(%)
  • Axis Bank
    1,257.00 1,418.30(%)
  • NSE
    1,717.00 1,712.00(%)
  • ICICI Bank
    1,340.00 1,187.55(%)
  • Moneyview
    55.62 48.33(%)
  • Reliance Industries
    1,173.00 1,161.00(%)
  • LIC Housing Fin.
    547.50 598.00(%)
  • Cupid
    357.45 357.45(%)
  • HDFC Bank
    690.65 682.00(%)
  • One 97
    1,560.60 947.10(%)
  • Larsen & Toubro
    3,606.10 3,288.65(%)
  • Bharti Airtel
    1,790.35 1,726.05(%)
  • Titan Company
    4,364.00 3,470.60(%)
  • TCS
    2,059.40 1,976.00(%)
  • Petronet LNG
    288.00 235.45(%)
  • United Spirits
    1,308.10 1,210.40(%)
  • Senco Gold
    359.00 430.00(%)
  • Jindal Steel
    1,002.00 978.20(%)
  • Kotak Mah. Bank
    433.05 345.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
140.53 -6 (-4.15%)
  • As on 08 Oct 2026 (EOD)

  • Today’s Low

    140.10

  • Today’s High

    149.69

  • Open

    149.69

  • Perv Close

    146.61

  • 52W Low

    59.31

  • 52W High

    152.50

Key Indicators

  • P/E(TTM)

    200.93

  • Mar.Cap (₹Cr.)

    754.06

  • Div & Yield %

    0.00

  • Book Value(₹)

    52.94

  • Debt-Equity Ratio

    -4.15

  • AGM Date

    08-Oct-2026

  • EPS

    0.70

  • P/E Ratio

    200.93

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    754.06

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    53.66

  • BV (₹)

    52.90

  • Sales( ₹ in Cr.)

    370.48

  • NP (in Cr.)

    4.41

  • NP Var(%)

    -62.0

  • Div%

    0.0

  • CPS (₹)

    4.40

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    754.71

  • 52 Week High

    152.50

  • 52 Week Low

    59.31

  • Price BSE

    141.0

  • Price NSE

    141.00

  • Market Capital( in Cr.)

    754.71

  • P/C Ratio

    31.80

  • P/E Ratio

    171.60

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 370.48 375.64 365.47 396.53 329.49 303.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 370.48 375.64 365.47 396.53 329.49 303.63
Other Income 11.39 5.62 4.69 6.43 4.51 2.45
Stock Adjustments 6.14 -1.27 14.05 -16.46 9.67 1.11
Total Income 388.01 379.99 384.21 386.50 343.67 307.19
EXPENDITURE :            
Raw Materials 170.66 166.58 185.49 182.37 170.02 159.74
Power and Fuel Cost 18.17 17.39 13.47 11.09 9.14 7.04
Employee Cost 60.10 56.41 50.81 46.47 38.63 34.48
Other Manufacturing Expenses 38.46 32.14 31.97 27.30 23.76 19.02
Selling and Administration Expenses 54.47 52.04 51.66 55.69 54.44 43.70
Miscellaneous Expenses 5.19 6.54 6.03 5.95 5.24 9.12
Employee Benefit Expenses 60.10 56.41 50.81 46.47 38.63 34.48
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 347.04 331.10 339.42 328.87 301.23 273.11
Operating Profit 40.97 48.89 44.79 57.63 42.44 34.08
Interest 13.20 11.39 6.92 5.58 8.31 10.89
Gross Profit 27.77 37.50 37.87 52.05 34.13 23.19
Depreciation 19.37 19.89 14.83 16.13 14.84 14.61
Profit Before Tax 8.40 17.61 23.04 35.92 19.29 8.58
Current Tax 3.28 4.45 0.83 6.28 3.40 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.84 1.42 5.45 4.63 2.88 2.95
Reported Net Profit 5.97 11.74 16.76 25.01 13.01 5.62
Extraordinary Items 1.56 0.08 -0.01 0.00 0.00 -3.39
Adjusted Net Profit 4.41 11.66 16.77 25.01 13.01 9.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 163.94 152.73 136.36 111.81 98.76 93.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.10 0.54 0.38 0.46 -0.05 0.39
P & L Balance carried down 169.81 163.94 152.73 136.36 111.81 98.76
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.11 2.41 3.44 5.13 8.01 3.46
Earnings Per Share(Adj)-Unit Curr 1.11 2.41 3.44 5.13 2.67 1.15
Book Value 53.07 49.90 47.60 39.85 104.73 96.69
Book Value(Adj)-Unit Curr 53.07 49.90 47.60 39.85 34.91 32.23

Shareholding Pattern

  • Promoter Group

    30.36%

  • Public Share Holding

    69.64%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,256,550 30.36 16,256,550 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,256,550 30.36 16,256,550 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,660 0.03 16,660 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 571,629 1.07 571,629 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 141,918 0.27 141,918 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 730,207 1.36 730,207 3
2] Non Institution
Bodies Corporate 9,023,858 16.85 8,976,158 103
Clearing Members 25,908 0.05 25,908 8
Directors of their Relatives 701,237 1.31 701,037 7
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,402,609 4.49 957,001 272
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 428,887 0.80 428,887 287
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,317,062 17.40 9,271,942 78
Individuals holding nominal share capital up to Rs. 1 lakh 7,720,294 14.42 6,872,994 13,724
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,942,380 3.63 1,942,380 3
Sub Total 36,562,280 68.28 34,176,352 14,500
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,549,037 100.00 51,163,109 14,510

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015

  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar Daud

  • Managing Director

  • Company Secretary

    Piyush Nikhade

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 140.65 381.87 370.48 200.93 4.92
Abbott India 25,629.80 7,217.19 6,929.05 33.73 43.78
Astrazeneca Phar 5,704.05 2,304.07 2,275.58 84.07 27.86
Glaxosmi. Pharma 2,534.65 3,932.76 3,790.20 40.49 58.17
Novartis India 1,986.40 393.10 354.33 50.16 15.94
Cipla 1,305.00 20,102.60 18,979.95 34.30 13.88
Bliss GVS Pharma 671.30 773.53 729.81 62.39 12.51
Fermenta Biotec. 537.85 474.15 450.25 25.11 18.77
Amrutanjan Healt 504.25 520.13 502.55 27.01 24.16
Guj. Themis Bio. 367.80 168.25 165.82 98.34 18.05
Ambalal Sarabhai 41.23 19.52 3.94 76.35 6.77